
    
      This is a 6 month study in which children on another anticonvulsant would have EEG, language
      testing, and a clinic visit at baseline. They would then be rapidly transitioned off of their
      current anticonvulsant and onto levetiracetam (Keppra). Repeat EEG and language testing would
      be done after 6 months to evaluate for improvement.
    
  